Extensive research indicates that the etiology of breast cancer is complex and multifactorial and may include environmental risk factors. Breast cancer etiology and exposure to xenobiotic compounds, diet, electromagnetic fields, and lifestyle have been the subject of numerous scientific inquiries, but research has yielded inconsistent results. Biomonitoring has been used to explore associations between breast cancer and levels of environmental chemicals in the breast. Research using breast tissues and fluids to cast light on the etiology of breast cancer is, for the most part, predicated on the assumption that the tissue or fluid samples either contain measurable traces of the environmental agent(s) associated with the cancer or that they retain biological changes that are biomarkers of such exposure or precursors of carcinogenic effect. In this paper, we review breast cancer etiology research utilizing breast biomonitoring. We first provide a brief synopsis of the current state of understanding of associations between exposure to environmental chemicals and breast cancer etiology. We then describe the published breast cancer research on tissues and fluids, which have been used for biomonitoring, specifically human milk and its components, malignant and benign breast tissue, nipple aspirate fluid (NAF) and breast cyst fluid. We conclude with a discussion on recommendations for biomonitoring of breast tissues and fluids in future breast cancer etiology research. Both human milk and NAF fluids, and the cells contained therein, hold promise for future biomonitoring research into breast cancer etiology, but must be conducted with carefully delineated hypotheses and a scientifically supportable epidemiological approach.
Introduction
Recently, the National Cancer Institute reported that breast cancer incidence rates increased by 0.4% per year from 1987 to 2002, a slower rate of increase than reported for previous years, and death rates have declined slightly (Edwards et al., 2005) . However, breast cancer remains the most prevalent cancer among women of all races in the United States (Brody and Rudel, 2003) .
Extensive research has shown that the etiology of breast cancer is complex and multifactorial. The pathophysiology of cancer, in general, occurs in a series of steps, which include initiation, progression, and proliferation whereby a normal cell is mutationally activated. For the most common type of breast cancer, infiltrating ductal carcinoma, malignant neoplastic changes occur in epithelial cells that line ductal tissues (McPhee et al., 2006) . Factors associated with increased breast cancer risk include early age at menarche, late age at menopause, late age at first full-term pregnancy, and nulliparity (Kelsey et al., 1993; Madigan et al., 1995; Adami et al., 1998; Phillips et al., 2002; Raaschou-Nielsen et al., 2005) . Regardless of a woman's age at first birth, multiple full-term pregnancies have been shown to decrease breast cancer risks in women after 40 years of age, but may increase the risk for breast cancers in women younger than 40 (Kelsey et al., 1993) . Other risk factors include inheritance of high-penetrance susceptibility genes, increasing age, exposure to ionizing radiation, family history of breast cancer, higher socioeconomic status, and prior benign breast disease (Kelsey et al., 1993) . Although the role of the menstrual cycle in breast cancer etiology is uncertain, shorter intervals between menstrual periods appear to be associated with increased risk (Kelsey et al., 1993) . The etiologic role of factors such as increased intervals between births, spontaneous and induced abortion, infertility, multiple births at last pregnancy, and hypertension during pregnancy are not yet clearly understood. Some data suggest that long-term combined estrogen/progestin hormone replacement therapy and long-term use of oral contraceptives increase the risk of breast cancer but, again, the relationship is not certain (Kelsey et al., 1993) . However, moderately increased risks linked to longterm estrogen replacement therapy and obesity in postmenopausal women indicate that estrogen alone influences breast cancer risk (Kelsey et al., 1993) .
Environmental factors, including exposure to xenobiotic compounds, diet, electromagnetic fields, and lifestyle have been the subject of numerous scientific inquiries (Labre`che and Goldberg 1997; Laden et al., 2001; Snedeker 2001 ). Yet studies investigating possible associations between breast cancer and exposure to xenobiotic compounds, such as persistent organochlorine compounds, have yielded inconsistent results. (Although some studies on passive or active smoking have shown an association with increased risk of breast cancer (Johnson, 2005) , studies incorporating breast biomonitoring were not located.)
The timing of exposure to environmental risk factors is an important consideration when studying breast cancer etiology. Pre-pubescent, pubescent, prenatal, and perinatal exposures to xenobiotics, as well as exposures during pregnancy, when rapid breast cell proliferation and development occurs, may affect a woman's breast cancer risk later in her lifetime. During these time periods, breast tissues may be more vulnerable to the potential effects of environmental exposures (Brody and Rudel, 2003) . Although it is important to obtain information on timing, duration, and magnitude of exposures, the conduct of such longitudinal studies is extremely resource intensive.
One method of gathering data on exposure is to examine levels of chemicals in the body rather than in the environment in which the person lives. Biomonitoring, the process of collecting environmental chemical data from human fluids and tissues, can provide information to: (1) ascertain the types of environmental chemicals present in the body; (2) identify trends in the levels of environmental chemicals in individuals or populations over time; (3) identify characteristics of highly exposed groups; (4) evaluate performance of interventions; and (5) investigate whether levels of environmental chemicals in humans are associated with higher risk of disease (Neutra, 2002) . It should be noted, however, that biomonitoring cannot address the route of exposure or timing of exposure (although for certain chemicals, timing of exposure may be assessed by comparing the concentration of the parent compound to the metabolite), particularly for chemicals that persist in the body. Thus, biomonitoring research to date has focused primarily on the detection of environmental chemicals in various fluids and tissues and, in some cases, on associations with breast cancer (LaKind et al., 2003) .
This paper provides a review of breast cancer etiology research utilizing breast biomonitoring (i.e., this review does not consider literature on biomonitoring of serum or tissues not from the breast). First, we give a brief synopsis of the current state of understanding the role of exposure to environmental chemicals in breast cancer etiology. Next, research on biomonitoring of environmental chemicals in breast tissues and fluids is reviewed. The types of tissues and fluids available for biomonitoring of the breast are described, along with their research advantages and limitations. The tissues and fluids described here are human milk and its components, malignant and benign breast tissue, nipple aspirate fluid (NAF), and breast cyst fluid. We conclude with recommendations for biomonitoring of breast tissues and fluids in future breast cancer etiology research.
The role of environmental chemicals in breast cancer etiology
The plausibility of an environmental etiology for breast cancer is supported by the following (Li et al., 1996) : (a) several compounds in the environment have been shown to be potent rodent mammary carcinogens; (b) lipophilic compounds can be stored and concentrated in breast lipid, and human mammary epithelial cells can metabolize these chemicals into species capable of binding to DNA; and (c) the distribution of p53 gene mutations observed in breast tumors points to involvement of exogenous chemicals in inducing these mutations. Others have considered the xenoestrogenic effect of organochlorine compounds (DeBruin and Josephy, 2002) , hypothesizing that their estrogenic activity can stimulate breast cell proliferation and induce or promote cancer (DeBruin and Josephy, 2002) . Associations have also been explored between exposure to carcinogens in the human diet and breast cancer DeBruin et al., 2001) , and exposure to organic solvents and breast cancer (Labre`che and Goldberg, 1997). (Others have researched laboratory animal exposure to environmental chemicals and mammary gland cancer (e.g., Snyderwine et al., 2002; Shan et al., 2004) ; these toxicology studies are not reviewed here). The protective role of breastfeeding for the mother has been examined in the context of the change in concentrations of environmental chemicals over the course of lactation. Estrogens, diet, and breastfeeding are discussed further below.
Estrogens
Cumulative exposure to estrogen is implicated in the etiology of human breast cancer from both toxicological and epidemiologic studies. Protective effects of factors associated with decreased cumulative estrogen exposure (e.g., late menarche, early menopause, lower alcohol consumption, young age at first full term pregnancy) have been reported (Henderson and Fiegelson, 2000) ; however, this association has not been found consistently across studies (Magnusson et al., 1998) . The hypothesis that estrogenic activity of xenoestrogens such as organochlorine compounds stimulates breast cell proliferation thus promoting cancer (DeBruin and Josephy, 2002) is not universally accepted (Safe 1997; Hindle 1999; DeBruin and Josephy, 2002) . Understanding whether xenoestrogens cause hormonally induced cancers is complicated by varying exposures to ''natural'' dietary substances with hormonal and antihormonal properties, and by their different estrogenic or antiestrogenic potencies (Safe and Zacharewski, 1997 ).
Diet
Results from several studies support the hypothesis that exposure to environmental agents in the diet is linked to breast cancer etiology. First, women who consume well-done and charred meats are reported to have an increased risk of breast cancer (De Stefani et al., 1997; DeBruin et al., 2001 ). Second, well-done meats contain heterocyclic amines and polycyclic aromatic hydrocarbons (PAHs), which have been shown to be mutagenic in short-term assays and carcinogenic in laboratory animals (DeBruin et al., 2001; Jeffy et al., 2002) . Third, heterocyclic amines and monocyclic amines have been detected in human milk (e.g., 13-59 p.p.t. PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine)) (DeBruin et al., 1999; DeBruin et al., 2001) , and heterocyclic amines and PAHs can form DNA adducts in human mammary epithelial cells (El-Bayoumy 1992; Lightfoot et al., 2000) , possibly resulting in mutation and cancer initiation (Felton et al., 2002) . Thus, these compounds come into contact with the breast, and in particular the ductal cells, the site of origin of most breast cancers. However, minimal research has been conducted on the relationship between diet, including cooked meats, and occurrence of breast cancer. Dos Santos Silva et al. (2002) found that, compared with lifelong meat eaters, lifelong vegetarians had a small, statistically insignificant, reduction in the risk of breast cancer (odds ratio ¼ 0.77; 95% confidence interval ¼ 0.50-1.19). The decreased risk appeared to be associated with increased consumption of certain vegetables rather than no consumption of cooked meat, and information on cooking methods for consumed meat was not given. Key et al. (1999) did not report a decreased risk of mortality from breast cancer for women with vegetarian diets. However, this was a mortality study, not an incidence study, and the authors did not adjust for reproductive risk factors. Carmichael et al. (1996) noted that studies of the incidence of breast cancer among migrant populations point to dietary and/or environmental factors in the etiology of breast cancer.
Breastfeeding and elimination of environmental chemicals
Lipophilic compounds may be stored and concentrated in breast lipids. Breastfeeding is a route of elimination of lipids from the mother, and therefore is also a route of elimination for lipophilic compounds present in the body (and assuming equilibrium among lipid compartments, also a route of elimination of those chemicals from the breast). It is possible that breastfeeding could therefore reduce exposure of the breast epithelial cells to lipophilic exogenous compounds and reduce the risk of breast cancer. (Breastfeeding has been shown to lower concentrations of certain lipophilic chemicals in human milk, although these reductions have been demonstrated for human milk, not breast lipid itself, and the rates of elimination for different compounds and different individuals can vary considerably (LaKind et al., 2001) ). Although investigations of associations between reduction of lipophilic chemicals by breastfeeding and risk of breast cancer to the mother have not been conducted to date, there are published reports of a protective effect (i.e., lower risk of breast cancer) for the mother with increased duration of breastfeeding (Collaborative Group, 2002; Jernstro¨m et al., 2004) . Although this is indirect evidence, it should generate interest in the hypothesis connecting lipophilic chemical exposure and breast cancer. However, the association between breastfeeding duration and decrease in risk of breast cancer in the mother is tentative. Even as some have reported a relationship between breastfeeding or duration of breastfeeding and reduced rates of breast cancer (Fraumeni and Miller, 1971; Zheng et al., 2000a; Collaborative Group, 2002; Lee et al., 2003) , others have found the protective effect of prolonged breastfeeding to be limited mainly to premenopausal women and to be a relatively weak effect (Brinton et al., 1995; Lipworth et al., 2000) .
Just as breastfeeding is associated with decreased levels of lipophilic chemicals in the mother, it is also associated with increased body burdens of those same chemicals in the nursing infant (Kreuzer et al., 1997; LaKind et al., 2000; Lorber and Phillips 2002) . If breastfeeding lowers the levels of carcinogens in the breast fluid, this could increase the risk to the child being breast-fed. However, studies of adults who were breast-fed as infants have consistently shown that having been breast-fed does not result in increased breast cancer risk later in life (Bucalossi and Veronesi 1957; Tokuhata 1969; Henderson et al., 1974; Ekbom et al., 1993; Freudenheim et al., 1994; Weiss et al., 1997; TitusErnstoff et al., 1998; Potischman and Troisi, 1999; Martin et al., 2005) . These investigations have focused on women who may have been breast-fed in the years before the extensive environmental distribution of lipophilic chemicals, such as dichloro-diphenyl-trichloroethane (DDT). Evaluation of the impact of early life xenobiotic exposures and nutritional influences on breast cancer requires more rigorous studies than those currently available (Potischman and Troisi, 1999) . Breast-fed infants do not appear to be at increased risk for childhood cancer as compared with formula-fed infants (Davis, 1998) , and breast-fed infants may be better able to manage future exposures to carcinogens due to modulation of the interaction between infectious agents and the immune system of the infant or by direct affect on the long-term development of the immune system (Davis, 1998) . There may also be a reduced risk for breast cancer in premenopausal women who had been breast-fed (Martin et al., 2005) .
As described in the following section, consensus has not been reached on the scientific evidence supporting or refuting exposure to xenobiotics as a causative factor in breast cancer etiology. Overall, the evidence suggests that although there may be a relationship between levels of certain environmental chemicals in the human breast and breast cancer, currently no specific environmental chemical exposure can be considered a cause of breast cancer (Laden and Hunter 1998; Snedeker 2006 ).
Breast biomonitoring of environmental chemicals -what has research revealed?
Monitoring levels of environmental chemicals in human breast tissues and fluids can yield exposure information for two target populations: women and breast-fed offspring. The breast tissues and fluids that have been the focus of investigations include human milk and its constituents, malignant and benign breast tissue, NAF, breast cyst fluid, and ductal epithelial cells derived from these tissues and fluids. For investigations into the etiology of breast cancer, each of these has advantages and disadvantages. Choice of biomonitoring matrix is determined by age and other characteristics of the women from whom the samples can be obtained, the volume of sample available for analysis, the origin and composition of the tissue/fluid, practicality of obtaining the sample, and whether the tissue is thought to have a relationship to the development of breast cancer. A fundamental characteristic is whether the sample could be obtained (i.e., milk samples from lactating women, cyst fluid from women with cysts) and the willingness of the woman to provide a sample. In the following sections, we describe each of the fluids and tissues, discuss their relevance to breast cancer in terms of environmental chemical biomonitoring, and review important research results that may provide direction for future biomonitoring efforts for studying breast cancer etiology.
Human milk and its components
Recommendations have been made to monitor human milk as part of an effort to explore breast cancer etiology because levels of environmental chemicals in human milk may reflect the levels of those chemicals in the breast tissue itself (State of California, 2003) . In light of the heightened interest in the use of human milk as a fluid for biomonitoring of levels of environmental chemicals in humans, an exploration of the hypothesis that human milk is an effective fluid for understanding potential environmental links to breast cancer is worth examining. We first provide a brief description of human milk biomonitoring, and then review published breast cancer research results which have focussed on human milk or its components. We discuss potential relevance to future breast cancer research in the Discussion section of the paper.
The first report of the presence of environmental chemicals in human milk appeared in the 1950s (Laug et al., 1951) . Since that time, hundreds of papers on levels of environmental chemicals in milk have appeared in the published literature. Although these studies have focused on a relatively limited number of chemicals, and although differences in study design have made interstudy comparison difficult (LaKind et al., 2001) , their results have nonetheless provided fundamental information on geographic and temporal trends of several environmental chemicals in human milk. A complete review of the findings of these studies is beyond the scope of this paper; readers are referred to reviews on the subject for detailed information (for example, Jensen and Slorach 1991; Sonawane, 1995; Smith 1999; LaKind et al., 2001 LaKind et al., , 2004 Solomon and Weiss 2002; LaKind, 2007) . With some exceptions, these investigations have not examined potential relationships between health outcomes and levels of chemicals in human milk. Most of the exceptions have been related to health outcomes of the breast-fed infant and, to our knowledge, none have used levels of environmental chemicals in milk as bioindicators of breast cancer in the mother or offspring.
Advantages to using human milk for biomonitoring are that a large volume of lipid-rich fluid (up to 100 ml of milk with typically between 3% and 5% lipid) is usually available and samples can be obtained in a relatively noninvasive manner (either by manual expression or by pump) (detailed methodological guidance has been developed by Expert Panels at the Technical Workshops on Human Milk Surveillance and Research on Environmental Chemicals in the US (LaKind, 2002 (LaKind, , 2005 . Both milk and ductal epithelial cells can be obtained with these sampling methods. The age range of women who can participate in this type of study is between menarche and menopause, although women in their 20 s to early 40 s are the most likely participants.
Although a focus on chemicals in human milk would exclude from study nulliparous and non-lactating women F a population thought to be at increased risk for breast cancer (Wolff and Berkowitz, 2002) , interesting research involving human milk and its components suggests that human milk should continue to be considered in designing investigations into breast cancer etiology. We describe research results from three promising areas of investigation: changes in ductal epithelial cells in human milk, analysis of human milk samples for mammary carcinogens, and investigations of the mutagenicity of human milk samples.
Ductal epithelial cells
Women are exposed to dietary and environmental carcinogens, which can react with the DNA of breast ductal epithelial cells. Ductal epithelial cells in human milk are important in breast cancer research because: (i) the cells can be obtained noninvasively, (ii) viable cells from fresh human milk can be isolated and cultured for study, (iii) genetic damage in the form of DNA adduction can be studied, (iv) identification of adducts can provide information on agents responsible for initiation of breast cancer as the cells reflect what actually occurs in the part of the breast in which most cancers arise, (v) the concentrations of chemicals in milk give information on breast cell exposure, biologically effective doses, and local metabolic processes, (vi) adduct levels as a function of exposure and genetic polymorphisms can be examined, (vii) milk composition of genotoxins may reflect levels of genotoxins in breast lipids as breast lipid turnover occurs during lactation, and (viii) the majority of breast cancers derive from luminal epithelial cells (Thompson et al., 1998; Martin et al., 2000b; GorlewskaRoberts et al., 2002; Phillips et al., 2002) . Thus, adducts of environmental chemicals in milk indicate exposure of the ductal epithelial cells to compounds that may act as mammary carcinogens. In addition, exfoliated cells in human milk can be used for the study of metabolic activation of suspected carcinogens (Martin et al., 2000b) .
Practical information for future breast cancer investigations using ductal epithelial cells is available (Thompson et al., 1998) . For example, DNA yield is significantly associated with number of weeks post-partum that a milk sample is collected (optimal yield 6-8 weeks post-partum) (Thompson et al., 1998) . In one study, 56%, 71%, and 84% of cells in human milk samples were epithelial at 4 weeks, 2-4 months, and 4-6 months, respectively (Thompson et al., 1998) . There do not appear to be significant associations between the number of cells recovered and milk volume, method of collection, number of samples collected from an individual over 24 h, or whether the infant has nursed before sample collection (Thompson et al., 1998) .
Genotoxic components in adipose tissue could reach breast epithelial cells by such mechanisms as return to the general circulation through the lymphatic system, by diffusion through the basement membrane, or by uptake by an active pinocytotic mechanism . If so, lactation would not be a prerequisite for the epithelial cells to be exposed to genotoxic agents originating in the adipose tissue . This does not, however, undermine the positive aspects of using human milk in breast cancer etiological investigations. In fact, because carcinogens can react with DNA in breast ductal epithelial cells, the cells from which cancers commonly arise (Gorlewska-Roberts et al., 2002) , collection of human milk as a source of these cells is a promising avenue for breast cancer research.
Potential drawbacks associated with the use of ductal epithelial cells from human milk in breast cancer research have been suggested and will need to be carefully evaluated. These include: (i) the ductal cells may be different in lactating and nonlactating women, (ii) hormonal profiles may affect cell processes, and (iii) factors related to milk production may affect metabolism of chemicals of interest (Thompson et al., 1998) .
Common environmental chemicals of interest in the study of DNA adducts include heterocyclic amines found in cooked proteinaceous foods, such as meat and fish, and aromatic amines and PAHs found in fossil fuel products, tobacco smoke, air and water (Gorlewska-Roberts et al., 2002; McClure et al., 1999) . Gorlewska-Roberts et al. (2002) examined the DNA of exfoliated ductal epithelial cells in 64 samples of human milk collected 4-6 weeks post-partum from non-smoking, healthy mothers. Of these, 30 samples contained PhIP adducts, 18 had 4-aminobiphenyl adducts, and 13 had B[a]P (benzo[a]pyrene) adducts. Interestingly, these compounds are basic, and it has been reported that chemicals related to human milk's mutagenicity are found in the basic fraction of the milk sample (Wheat et al., 2001; Phillips et al., 2002; Thompson et al., 2002) . This study demonstrates that dietary and environmental carcinogens react with DNA in breast ductal epithelial cells, suggesting that these chemicals should be the focus of additional investigations.
Environmental and dietary carcinogens in human milk
Compounds including PhIP, aniline, and monocyclic aromatic amines have not only been found as DNA adducts in ductal epithelial cells but have also been detected in human milk (DeBruin et al., 2001; DeBruin and Josephy, 2002) . Total heterocyclic amine intake resulting from a typical Western diet is 1.4 mg/day, with PhIP present in human milk at the parts per trillion level (DeBruin et al., 2001) . Vegetarians may be an exception; in a milk sample from one vegetarian, no PhIP was detected. Women who consume very well-done meat have a 4.6-fold increased risk of breast cancer compared with those eating rare or medium cooked meat (DeBruin and Josephy 2002) . Heterocyclic amine exposure through intake of well-done meats is a biologically plausible risk factor for breast cancer (DeBruin and Josephy, 2002) , supported by information showing that DNA from breast tissue of cancer patients has higher levels of DNA adducts than that from healthy controls. In addition, mammary epithelial cells can bioactivate PhIP to reactive genotoxic species (DeBruin et al., 2001) . A correlation between adduct levels (arylamine adducts) and recent consumption of meat suggests that arylamines may be related to breast cancer risk (McClure et al., 1999) . The use of human milk for both the determination of the presence (and levels of) mammary carcinogens and DNA adducts in ductal cells and the relationship with breast cancer incidence should be one focus of future research.
Mutagenicity of human milk
In addition to the use of human milk for analysis of environmental chemicals and DNA adducts in ductal epithelial cells, human milk has been examined for its mutagenic properties. Human milk (and breast lipid) contains components capable of causing genotoxic damage in test systems and human breast cells, events possibly linked to breast cancer initiation. Advantages of using human milk over adipose tissue include (Martin et al., 1999) : (i) milk is more readily available and non-invasively obtained; (ii) multiple samples can be obtained to study time course fluctuations in mutagenic activity; and (iii) less extensive sample digestion is required. In addition, human breast cells extracted from milk samples provide a source of material for investigating the presence of pre-existing DNA damage and for genotyping (Martin et al., 1999) . Martin et al. (1999) investigated the genotoxicity of 20 human milk extracts (based on their ability to cause mutations in S. typhimurium TA1538 and YG1019 and to induce micronuclei and DNA strand breaks in MCL-5 cells) and DNA damage in exfoliated ductal epithelial cells recovered from the milk. Human milk extracts were found to cause positive mutagenic response in bacterial strains and DNA damage (i.e., DNA single-strand breaks) in viable exfoliated breast cells from fresh milk (both from the donor's own milk and other donors' milk).
In a similar study, Martin et al. (2001) investigated the ability of human milk extracts to induce DNA single-strand breaks, cause mutations in S. typhimurium YG1019, and induce micronuclei in MCL-5 cells. Their study participants were from both a western country (UK, n ¼ 32) and eastern countries (Hong Kong, India, Singapore, n ¼ 50). Their results suggest that genotoxic components occur in significantly more human milk samples from women in the UK, a country with higher breast cancer rates, as compared with the milk from mothers from Hong Kong, India, and Singapore, countries with lower incidences of breast cancer. This type of research points to the need for epidemiological follow-up studies to determine whether women with higher levels of genotoxic components in their milk are at higher risk of breast cancer later in life. Additional research is needed to isolate and characterize genotoxins in human milk and to investigate inter-country, and perhaps regional, differences in genotoxicity of human milk.
As noted earlier, one hypothesis for the potentially protective effect of breastfeeding against the development of breast cancer in the mother relates to the reduction in the mother's body burden of certain environmental chemicals over the course of lactation. However, comparisons of cells and human milk extracts between samples taken early and late post-partum do not support the hypothesis of a progressive removal of genotoxins from mammary lipid during lactation (Martin et al., 2000a) . This was demonstrated by analyzing human milk extracts and human milk cells taken 2-10 weeks (early) and 13-34 weeks (late) postpartum from 16 breastfeeding volunteers (the number of weeks between collection of the first and second samples ranged from 9 to 19). Rather than observing a decline in genotoxic activity of milk extracts over that time period, the authors reported fluctuations in genotoxic activity of the extracts of early and late milk samples provided by the same donors, suggesting variations in diet and/or lifestyle as the source of genotoxicity (Martin et al., 2000a) . Martin et al. (2000a) found that genotoxicity occurred in the absence of cytotoxicity, and that women whose untreated cells contained the most DNA damage tended to have genotoxic human milk extracts. Milk cells were also shown to convert PhIP and o-toluidine (rodent mammary carcinogens) to genotoxic metabolites. Milk extracts induced DNA single-strand breaks in the mother's own exfoliated breast cells. These results, based on a single study with a small cohort, need to be confirmed by a larger-scale study. Thompson et al. (2002) analyzed exfoliated ductal epithelial cells in milk samples from 50 women for the presence of DNA adducts and matched milk samples were tested for mutagenicity. DNA adducts were identified in 66% of the samples, whereas 88% of the whole milk samples demonstrated mutagenicity. The authors did not find a correlation between levels of adducts and levels of mutagenicity. Most mutagenicity was found in whole milk or skimmed milk (as opposed to the milk fat), suggesting that the mutagens are moderately polar, residing in the aqueous phase. No correlation between mutagenic activity of breast milk and urine from same subject was found. The lack of correlation in mutagenicity between milk and urine suggests that the mutagen activity observed with milk was a local phenomenon. As in previous research, the mutagens were also found to be basic compounds. Thompson et al. (2002) hypothesize that mammary mutagens may be difficult to verify as breast carcinogens in epidemiological studies because of the variation in individual bioactivation capabilities of the target tissue.
In summary, human milk is a readily available, lipid-rich matrix, which has been used in the investigation of environmental chemicals and breast cancer etiology. The identification of genotoxic agents in human milk, as well as the sources of these agents, may provide clues regarding the origins of some breast cancers . In seeking to identify the genotoxic components of human milk, investigators have determined that agents responsible for genotoxic activity in human milk appear to be moderately polar, basic, and of low molecular weight (Wheat et al., 2001; Phillips et al., 2002; Thompson et al., 2002) . The evidence for lipophilicity of these compounds is inconsistent. Pasteurization does not appear to affect genotoxicity of milk; samples of human milk from milk banks may be suitable for future study , if storage and collection methods are consistent. However, no information was found on potential affects of freezing the milk sample. The limitations in the use of human milk for epidemiological studies of breast cancer include: (i) the focus on a population with lower risk for breast cancer; (ii) the inclusion of a restricted cohort (limited age range; lactating women only).
Malignant and benign breast tissue
The non-lactating human breast is comprised of 70-90% adipose tissue by weight; the adipose tissue is of interest in breast cancer etiology research because the functional elements of the breast, lined with the epithelial cells from which cancers commonly begin, are distributed in the adipose tissue (Martin et al., 1996) . The biological plausibility for the relationship between environmental carcinogens in adipose tissue and breast cancer is supported by the close proximity of fat stores in the breast to the cells of origin of human breast cancer (Klein and Lawrence, 2002) . In addition, the mutational spectrum in the p53 gene in human mammary tumors differs from the spectrum associated with endogenous/background mutagenic processes. This suggests that breast cancer may be partly explained by exposure to mutagenic exogenous agents (Martin et al., 1996) , providing further biological plausibility for the association of breast cancer with breast tissue exposure to exogenous agents. Several investigations into levels of environmental chemicals in malignant and benign breast tissue have been undertaken; other studies have explored DNA adducts in breast tissue. These investigations are described here. (Breast adipose tissue is interspersed with non-fatty connective tissue, contributing to a range of percent lipids in breast adipose tissue of o10% to 100% (Petreas et al., 2004) . This underscores the importance of reporting concentrations of lipophilic compounds in breast adipose tissue on a lipid corrected basis (Petreas et al., 2004) .
Environmental chemicals in breast tissue
An early study of neoplastic and adjacent normal mammary and adipose tissue was conducted to determine relative concentrations of organochlorine compounds in these tissues. Nine women with malignant breast tissue and five women who died accidentally and who served as controls were included in this study. In the cancer patients, the highest levels of total DDT and polychlorinated biphenyls (PCBs) (lipid basis) were found in the malignant tissue as compared with adjacent mammary and adipose tissue, with levels in the latter two tissues comparable with levels in the controls (levels of total PCBs were statistically significantly higher in malignant tissue lipids as compared with adjacent tissue lipids) (Wassermann et al., 1976) . Unger et al. (1984) reported no significant differences between levels of DDT/DDE (1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene) and PCBs in breast fat tissue (lipid basis) of cancer patients (living, n ¼ 14; deceased, n ¼ 18) and non-cancer patients (living, n ¼ 21; deceased, n ¼ 35). The authors concluded that accumulation of these compounds in breast fat tissue is not related to the occurrence of breast cancer. In contrast, in a pilot study of 20 women with breast cancer and 20 women with non-malignant breast disease, statistically significantly elevated levels of PCBs, DDT, and DDE (wet weight basis) were found in the breast fat of women with cancer (Falck et al., 1992) , suggesting a role for these compounds in the etiology of breast cancer. No differences were found between the two groups of women for hexachlorobenzene (HCB), HCH (hexachorocyclohexane, lindane), or chlordane residues.
Breast lipid from women with and without breast cancer was used to investigate the potential relationship between breast cancer and levels of neutral organochlorine compounds and the antioxidants selenium, copper, and zinc (MussaloRauhamaa and Pantzar, 1993). The only chemical for which a positive correlation was found was b-HCH, with an odds ratio of 10.51 (95% confidence interval ¼ 2.00-55.26) for patients whose tissue levels of b-HCH were 40.1 mg/kg fat.
Breast tissue epithelial cells from women with a family history of breast cancer undergoing prophylactic mastectomies were used to establish primary cultures (Hu et al., 1997) . The cells were treated with either B[a]P or 7,12-dimethylbenz [a] anthracene. The in vitro study revealed phenotypic changes suggestive of early stages of neoplastic transformation not seen in similar in vitro studies with epithelial cells from breast tissue from women without a family history of breast cancer. The authors concluded that there is a genetic predisposition due to a family history of breast cancer that is associated with greater inherited susceptibility to environmental chemical carcinogens.
Levels of DDT, DDE, DDD (1,1-dichloro-2,2-bis (p-chlorophenyl) ethane), HCB, HCHs, and PCBs were determined in breast tissue from 45 women diagnosed with breast cancer and 20 with benign breast disease (Gu¨ttes et al., 1998) . Generally, higher levels of several of these organochlorines were found in the tissue of women with breast cancer. However, this appears to have been related to the fact that the women with breast cancer were on average 11 years older than the control women. After adjusting for age, higher levels of DDT, DDE, HCB, and PCBs 118, 138, 153, and 180 (lipid basis) were found in tissues from women with breast cancer as compared with women with benign breast disease, with the greatest difference found for p,p 0 -DDE (62% higher in cancer patients). Women with benign breast disease had higher concentrations of PCBs 170 and 156 and b-HCH. Based on the results of this study as well as a review of previous research on this topic, the authors believe that there is no correlation between concentrations of these organochlorines in the body and breast cancer. Gu¨ttes et al., also note that for only two of these compounds (p, p 0 -DDE and PCB 153), the concentrations in human blood serum can be correlated with the concentration in breast tissue; this correlation does not apply for the majority of other organochlorine compounds. The authors recommend that future breast cancer etiology/biomonitoring studies focus on breast tissue rather than blood plasma or serum. Gu¨ttes et al. (1998) also analyzed both the tumor and bordering tissues for these organochlorine compounds to explore the potential influence of surgical procedures on the levels of organochlorine compounds in the breast. Rapidly growing malignant tumors can cause increased decomposition of surrounding lipid tissue, resulting in a release of organochlorines from the lipid and subsequent sequestering in the lipochrome border of the tumor. Thus, the method used to sample the cancerous tissue (the center of the tumor or the surrounding tissue) could affect the concentrations of organochlorines in the sample. The differences in concentrations of organochlorine compounds measured were inconsistent and minimal, indicating no localized enrichment of organochlorines at the lipochrome border of the tumor.
In a study of 304 breast cancer cases and 186 benign breast disease controls in Connecticut, no association was found between breast adipose tissue levels (lipid basis) of DDE or DDT and breast cancer risk (Zheng et al., 1999a) . With the same cohort, Zheng et al. (1999b) found no significant differences between lipid-adjusted levels of HCH (lindane) in cases and controls, in contrast to the results of MussaloRauhamaa and Pantzar (1993). The difference in study results may be due to chance (because of the small sample size in the 1993 study), the higher levels of HCH in the earlier study, or the inclusion in the Zheng et al., study of control women with benign breast disease (Zheng et al., 1999b) . Further, Zheng et al. (2000b) found no increased risk of breast cancer associated with breast adipose levels (lipid basis) of oxychlordane or trans-nonachlor with this cohort.
Breast adipose tissue samples from women undergoing excision biopsies from 217 cases and 213 benign controls was analyzed for PCBs, p,p 0 -DDT, p,p 0 -DDE, cis-and transnonachlor, oxychlordane, HCB, mirex, a-and g-chlordane, and b-HCH (Aronson et al., 2000) . Significant associations with breast cancer risk were found for several of the PCBs (especially for PCBs 105 and 118) measured in breast adipose tissue on a lipid basis. The results were inconsistent or null for the other compounds measured. Bagga et al. (2000) reported no association between lipidadjusted levels of DDT in breast adipose tissue from 73 women with breast cancer and 73 controls. Mean DDE and total DDT compound concentrations was statistically significantly higher in cases; however, this relationship was not observed after adjusting for age of participant. Thus, Bagga et al., conclude that on the basis of the observations in their study, there is not clear association between exposure to DDT compound and risk of breast cancer. Charles et al. (2001) analyzed 44 cancerous breast tumors and 21 tissue samples from benign biopsies of the breast for levels of DDT compounds and 18 PCB congeners. No significant differences were found in the lipid-adjusted concentrations of these chemicals between the cases and controls. In addition, because it has been hypothesized that oxidative DNA damage caused by organochlorine compounds is a factor in breast cancer etiology, the authors measured 8-hydroxy-2 0 -deoxyguanosine (8-OHdG), a biomarker of oxidative DNA damage, in cancerous and noncancerous breast tissue. No significant differences were observed in levels of 8-OHdG between the two tissue types and no correlation was found between 8-OHdG and the organochlorine compounds measured. Research to date is insufficient to confirm or counter the hypothesis that cytochrome P450 metabolism of organochlorine compounds results in oxidative DNA damage leading to breast cancer (Charles et al., 2001) .
Breast adipose tissue from 217 women with breast cancer and 213 control women was analyzed for 14 PCB congeners and 10 pesticides (p,p 0 -DDT, p,p 0 -DDE, cis-nonachlor, trans-nonachlor, oxychlordane, HCB, Mirex, b-hexachlorocyclohexane, a-chlordane, and g-chlordane) (Woolcott et al., 2001) . Associations between concentrations of these compounds (lipid basis) and breast cancer did not differ significantly by type of tumor (estrogen receptor (ER) status, progesterone receptor (PR) status, size, grade), but PCBs were more strongly associated with tumors of poor prognosis (ER-and PR-negative, size 42 cm, grade III). Rusiecki et al. (2004) measured PCBs in breast adipose tissue in 266 cases and 347 benign breast disease controls. The risk of breast cancer was examined in relation to levels of individual PCB congeners and total PCBs in lipids in adipose tissue (and serum), with cases stratified by tumor type (ER/ PR status). No clear association between PCB exposure and breast cancer was found.
Parabens, which are used as preservatives in cosmetics, foods, and pharmaceuticals, were measured in breast tumors from 20 women (Darbre et al., 2004) . Parabens were not measured in a control group. The mean concentration of total parabens in the breast tumors was 20 ng/g tissue.
Breast tissue (tumor and surrounding adipose tissue) from 50 women undergoing surgery for benign (n ¼ 25) and malignant (n ¼ 25) breast disease was analyzed for a-, g-, b-and d-HCH, and DDT compounds (Siddiqui et al., 2005) . Total HCH and total DDT (lipid basis) were higher in the tumor tissue of controls (with only g-HCH being statistically different). Total HCH was higher (a-HCH being significantly higher) in the adipose tissue of the cases, but total DDT was higher in the adipose tissue of the control group. The study, although of low statistical power, did not support a positive association between organochlorine exposure and breast cancer. Perera et al. (1995) conducted a pilot study with tumor and tumor-adjacent tissue from 15 women with breast cancer and normal tissue from four women undergoing breast reduction to determine whether adducts of environmental carcinogens could be detected in breast tissue. Mean aromatic/hydrophobic-DNA adduct levels were greater for the women with breast cancer than for control women. Li et al. (1996) used surgical specimens of breast tissue to measure aromatic DNA-carcinogen adducts in normal adjacent tissues from 87 breast cancer patients and normal tissues from 29 reduction mammoplasty non-cancer controls. Analysis was performed on DNA samples extracted from breast tissue epithelial cells after dissecting out surrounding fat. Total adduct levels were significantly higher in normal adjacent tissues of breast cancer patients compared with normal breast tissues of non-cancer controls. In this sample population, a benzo(a)pyrene-like adduct was found in normal adjacent tissue of 41% of the breast cancer patients but was not detected in any of the control breast tissues. These results suggest that DNA adducts may be a tool for demonstrating associations between carcinogen exposure and cancer risk.
DNA adducts and breast tissue
Mammary epithelial cells were obtained from the breast tissue of healthy women undergoing reduction mammoplasty . The tissue samples were treated with seven heterocyclic amine food mutagens, four nitropyrenes (components of auto combustion emissions), and one PAH (dibenzo[a,l]pyrene). DNA was isolated from the cultures and in each case the presence of carcinogen-DNA adducts was detected, demonstrating the ability of human breast epithelial cells to activate to DNA-binding species several carcinogens found in the human diet or in the environment. Martin et al. (1996) tested the hypothesis that human mammary lipid contains genotoxic/mutagenic compounds which could cause DNA damage in adjacent epithelial cells. Lipid samples were obtained from 40 women in the UK undergoing elective reduction mammoplasty. The results were mixed, with 40% of the samples testing positive for mutagenicity in the presence of an exogenous metabolic activation system (Aroclor 1254-induced rat-liver S9). The study demonstrated the presence of chemicals in extracts of normal human mammary lipid that induce point mutations in bacteria and chromosomal damage in human cells.
Human breast epithelial tissue can metabolize PAHs to their mutagenic/carcinogenic forms, which are capable of forming PAH-DNA adducts. PAH-DNA adducts in breast tissue from women with breast cancer (119 women) and women with benign breast disease (108 women) were measured (Rundle et al., 2000) . Neither active/passive smoking nor diet was significantly associated with PAH-DNA adducts or with breast cancer incidence. However, PAH-DNA adducts were significantly associated with breast cancer cases. The results suggest that genetic damage from exogenous sources of PAHs may be a risk factor for breast cancer causation or progression. Nonetheless, the predictive value of DNA-PAH adducts for breast cancer has not been established in prospective studies. Difficulties with this type of research include interindividual variability in PAH-DNA binding attributed to differences in PAH exposure, PAH activation/metabolism, DNA binding, and repair of PAH-DNA adducts (Rundle et al., 2000) (the formation of PAH adducts is via reactive diol epoxide intermediates that are formed from certain PAHs). An additional complication in interpreting results of these types of studies relates to the fat solubility of PAHs; they may accumulate in adipose tissue and be released and redistributed to breast epithelial cells, with adduct levels therefore reflecting both long-term and recent exposures (Rundle et al., 2000) . This limitation is also applicable to studies of other lipophilic chemicals such as organochlorine compounds.
In summary, studies to date have yielded conflicting results regarding associations between levels of environmental chemicals in breast tissue and breast cancer. This type of evaluation has focussed predominantly on persistent lipophilic compounds. Breast adipose tissue has been obtained from women undergoing voluntary reduction mammoplasty, breast biopsies or cancer surgery, or from accident victims. Of course, these are selected groups and not necessarily representative of all women. Sampling of breast adipose tissue is a clearly invasive procedure, cells from tissues from reduction mammoplasty are difficult to obtain, and sample preparation is labor intensive (Thompson et al., 1998) .
Nipple aspirate fluid
The ductal system of the breasts of non-pregnant women produce proteinaceous secretions F containing chemicals of endogenous and exogenous origin as well as epithelial cells F which can be sampled and utilized for breast cancer etiology research (King et al., 2005) and breast biomonitoring (Petrakis 1993a; Klein and Lawrence, 2002) . These secretions are called NAF. As early as the 1960s, it was hypothesized that ''ylocally formed toxic degradation products or carcinogenic compounds secreted into the breast ducts from the blood might be concentrated in relatively static breast secretions and be of significance in the etiology of benign breast disease and breast cancer'' (Petrakis 1993b) . According to Klein and Lawrence (2002) , ''Environmental mutagens would likely affect carcinogenesis through a direct exposure on the ductal cells and could be detected in fluid thus derived.''
The population of women who can participate in NAF studies is more inclusive than studies involving human milk or breast tissue. NAF is most readily obtained from Caucasian and African-American women (450% of these women yield fluid), with Asian women less likely to be able to provide fluid (B30-35%) (Petrakis, 1993a) . The age range of women most able to produce fluid is from 30 to 55 years of age. Wrensch et al. (1990) conducted a case-control study of breast disease with 1428 women to determine factors influencing the ability to obtain NAF from non-lactating women. Factors shown to increase the ability to obtain NAF are age range from 35 to 50 years, earlier age at menarche, non-Asian ethnicity, and history of lactation. Factors not associated with the ability to obtain NAF samples include exogenous estrogen use, endogenous estrogen levels, the phase of menstrual cycle, a family history of breast cancer, type of menopause (natural or surgical), and less than fullterm pregnancy. The investigators were able to obtain NAF from 42% of premenopausal women as compared with 17% of postmenopausal women. With newer methods for extracting fluids, investigators have been able to sample NAF from up to 60% of participating women (Klein and Lawrence, 2002) .
NAF can be obtained either by aspiration (Figure 1 ) or ductal lavage (Figure 2 ), the former a non-invasive and inexpensive method, the latter a somewhat more invasive method requiring experienced medical personnel (Klein and Lawrence, 2002) . The most substantial drawback is the small volume of fluid which can be obtained, ranging from 1 to 4200 ml (Petrakis, 1993a) . Larger sample volumes and greater numbers of epithelial cells can be obtained with ductal lavage (Klein and Lawrence, 2002) . Although analytical techniques for measuring most environmental chemicals in these sample volumes is not possible at this time, nicotine (reported levels of 46-195 ng/ml) (Petrakis et al., 1978) , cotinine, caffeine, and Ames test-positive chemicals suggesting the presence of mutagenic chemicals of unknown origin have been detected in NAF (Petrakis, 1986 (Petrakis, , 1993a . Total fatty acids have been found to be present in NAF samples at approximately 2 mg/ml (Petrakis, 1986) .
The value of NAF has been described by Malatesta et al. (2000) , referring to breast secretions as quick, repeatable, non-invasive means for obtaining fluid and cells. The breast is unique among secretory glands, because many chemicals in the secretions are retained and concentrated, possibly for long periods of time, and eventually metabolized by the breast epithelium or absorbed (Petrakis, 1993a; Malatesta et al., 2000) . This is of special interest for investigations into diseases of the breast, including breast cancer, because this peculiar secretory activity allows toxic, mutagenic, and carcinogenic substances, and hormones, proteins, and growth factors, to reach breast epithelium. Once they reach the epithelium, these compounds may be taken up and metabolically activated to produce direct and/or indirect intracellular effects on the breast epithelium (Malatesta et al., 2000) . NAF can be used to evaluate the proteinaceous secretory components that come into contact with the ductal epithelial cells, to investigate the properties of the ductal cells, and to assess the mutagenicity of the fluid (Klein and Lawrence, 2002; Klein et al., 2001) .
In a study of the mutagenicity of NAF from 170 women, the overall incidence of women with mutagenic activity was approximately 8% (Scott and Miller, 1990) . No significant association of mutagenic activity was found with age, menopausal status, presence of breast abnormality, family history of cancer, or parity. No common environmental characteristic among women providing NAF samples was observed. Further, one breast aspirate may yield positive mutagenicity results, whereas the other breast from the same woman can yield fluid with negative mutagenicity results, suggesting that accumulation of mutagens may be a local phenomenon (Scott and Miller, 1990) .
Another investigation of the mutagenicity of NAF with 612 samples from 456 women in California found positive results from fluid from approximately 7% of participating women (Petrakis et al., 1980) . The highest proportion of positive Ames tests was reported for women over 40 years of age (12.4% compared to 4.3% for women younger than 40).
NAF has great potential for breast cancer etiology research due to its non-invasive method for sampling and the inclusiveness of the participant pool (women of varied ages and non-lactating status). Important research needs for use of NAF in environmental chemical/breast cancer etiology research are methods for collection of longitudinal samples, and improved analytical methods for determining levels of environmental chemicals in the small-volume NAF samples along with cell cytology. In addition, to our knowledge, there are no published data on levels of total lipids in NAF, which will be needed to normalize data for lipophilic chemicals. Pooling of samples may be a useful approach until analytical techniques improve; however, it is not clear whether collection and pooling of longitudinal samples from one woman is practical, as discomfort may be too great.
Breast cyst fluid
A limited number of investigations of breast cancer etiology have focussed on fluids from breast cysts, which stem from fluid-filled vessels in terminal duct lobular units (Blackwood et al., 1998) . Approximately 7% of Western women have palpable breast cysts (Scott and Miller 1991) and cyst fluids (2.5-50 ml) (Tsung et al., 2005) can be obtained via fine needle aspiration.
Breast cysts are not typically sites of breast cancer or epithelial precursors, calling into question their clinical usefulness (Petrakis, 1993a) .
The results of one study raise questions regarding the distribution of environmental chemicals in various fluids in the human body. Blackwood et al. (1998) examined paired breast cyst fluid/plasma levels of PCBs and DDE. Although lipid-adjusted levels of DDE in plasma were significantly correlated with those in cyst fluid, this result was not found for PCBs. In fact, some PCB congeners were preferentially excluded from or concentrated in cyst fluid. In general, plasma levels of DDE and PCBs were higher than levels in cysts. The fact that cyst fluid is comprised of compounds whose concentrations may differ from those in plasma is important to consider when drawing conclusions about overall exposures based on cyst fluid measurements. Scott and Miller (1991) analyzed the breast cyst fluids in 439 women for the presence of mutagens. Mutagenicity of cyst fluids was evaluated with the Ames test. The overall incidence of cyst fluids showing mutagenic activity was 5%. Of interest is that an individual with multiple cysts can yield both positive and negative mutagenicity results. The authors also reported that mutagenic activity did not appear to be related to parity, menopausal state, family history of breast cancer, or use of cigarettes, hair dye, or pharmaceuticals. Scott and Miller (1991) noted that ''ythe observation that patients presenting with multiple cysts may have a mutagenpositive cyst at the same time as a negative cyst suggests that local or transient events are involved rather than a more general accumulation.'' The compound(s) responsible for mutagenic activity appeared to be organic, and possibly volatile or heat-sensitive. The compounds were also stable with changes in pH, suggesting non-ionic compounds. The clinical significance of mutagenic activity of these fluids is unclear.
In summary, very few studies on breast cancer etiology have used breast cyst fluid for examination of environmental chemicals. As this fluid is not thought to be directly related to the etiology of breast cancer, and because of the invasive method needed to extract the fluid from the relatively small percentage of women who have breast cysts, this fluid does not appear to the most promising biomonitoring matrix for future studies of environmental chemicals and breast cancer etiology.
Discussion and research recommendations
Numerous investigations have been conducted using breast biomonitoring to investigate breast cancer etiology. To date, research results have not found unequivocal evidence linking specific environmental chemicals to breast cancer. This does not mean that these types of investigations are of no value, but, as we have attempted to show, that more comprehensive and inclusive investigations are needed. ''Comprehensive and inclusive'' refers to the types of fluids and tissues obtained, the characteristics of women included, and the types of chemicals studied.
Breast tissues and fluids
A review of the published information on breast biomonitoring and breast cancer raises an important question: is biomonitoring of the breast even necessary? In other words, could investigators rely on other types of biomonitoring, such as measures of serum, to further breast cancer research? We believe that although important exposure information can be obtained by analyzing serum and other matrices for environmental chemicals, breast biomonitoring remains important because (i) the breast is the target organ, and (ii) there is conflicting evidence on whether levels of environmental chemicals in the body outside the breast reflect exposures to breast tissue (Archibeque-Engle et al., 1997; Aronson et al., 2000; Wolff and Berkowitz 2002; Rusiecki et al., 2004) . However, a sole focus on breast fluids and tissues does not consider earlier life stages (e.g., puberty) when breast sampling may not be possible (Table 1) . Because of the potential for critical etiologic exposures to occur in these earlier periods (DeBruin and Josephy, 2002; Birnbaum and Fenton, 2003) , other types of fluids (e.g., serum samples) are likely to remain essential for furthering investigations. To achieve this, archiving of biospecimens collected during younger ages will be necessary (Ward et al., 2000) , so that the information will be available in later life when breast cancer risk is higher. To investigate gene-environment interaction, genotype could be obtained from cells present in the archived specimens.
In suggesting future directions for biomonitoring of breast tissues and fluids in breast cancer etiologic research, one must first consider which of the several matrices discussed in this paper are likely to prove most useful. Much of the research to date has been performed with epithelial cells from human milk samples and from breast tissue from surgical procedures, but will these methods deliver the necessary information? The utility of any given tissue relates to the type of study F research versus surveillance. Breast tissue samples, such as tumor and benign tissue, can only be obtained invasively, which immediately limits their availability. Tissue samples may be taken at biopsy or autopsy, but the timing is not necessarily favorable for breast cancer etiologic research. Breast cyst fluid is potentially available only from the small proportion of women who have breast cysts and even then, requires an invasive technique and may not be related to breast cancers. Thus, its use is likely to remain confined to specialized investigations.
Although the large volume of milk that can be collected makes it an appealing matrix for breast biomonitoring, the limitations are significant in terms of the restricted (and potentially lower risk) population included in the cohort. In contrast, an advantage of NAF is that it can be obtained from women who are childless or non-lactating and from women over a wide age range (Table 1) . Unlike human milk, NAF can only be obtained in small quantities. Improvements in sensitivities of analytical methods may make the current NAF or ductal lavage volumes useful for biomonitoring research. In the meantime, if discomfort to the participant can be minimized, repeated longitudinal sampling from donors could possibly yield sufficient volume to render NAF an important matrix for breast biomonitoring of environmental chemicals, while at the same time providing ductal epithelial cells for study.
In summary, human milk and NAF are the breast sampling matrices of choice for future investigations into the relationship between environmental chemicals and breast cancer etiology. As neither of these fluids provides information on early life exposures, archiving of blood samples collected at younger ages would be a critical component of a comprehensive study (Ward et al., 2000) .
Study participants
Restricting study participation to breastfeeding women for biomonitoring and cancer etiology research has important limitations. First, human milk is obtained principally from women who have children. It is well established that having children is protective against breast cancer. Further, it has been reported that women who have breast-fed children have a lower risk of breast cancer than women who have not breast-fed their children (Collaborative Group, 2002) . Thus, seeking breast cancer associations with environmental chemicals in human milk is immediately limited to the subgroup of women (albeit a large one) who are at lower risk for breast cancer. The second limitation is that, for most women, the age at which breast cancer occurs is much later than the age at which lactation took place. This can also be viewed as an advantage in that the exposures measured may be at a time that is etiologically meaningful. As the ability to measure environmental chemicals in NAF improves, the cohort can be broadened to include women who have not had children or have not breast-fed. This still does not capture early life exposures that could be of etiologic importance (Wolff and Weston, 1997; Birnbaum and Fenton, 2003) . Recruiting participants at younger ages and collecting and archiving blood samples (Ward et al., 2000) is a more comprehensive and inclusive approach.
To utilize these three types of fluid as part of an overall biomonitoring strategy requires a willingness to think in terms of a longer time horizon than is common in today's results-oriented research environment. However, it is straightforward to conceive of an epidemiologic research design that is appropriately forward thinking. Conceptually, probably the most useful study design, taking into account the above considerations, would be a breast cancer casecontrol study nested in a prospective cohort study. For this purpose, it would be ideal to first collect and archive an adequate range of information on participating girls and women to permit useful interpretation of the future laboratory-generated results. In addition to an adequate time frame, key considerations are sufficient statistical power to be able to detect defined risks and a capacity to adapt to new technologies that will become available. Samples of blood, milk, and NAF could be collected and stored until a sufficient proportion of the cohort had developed breast cancer. Cohort size would be based on power calculations that took into account the expected proportion of the participating women who would develop breast cancer over the projected time frame of the study. It would be important to collect and store a range of relevant demographic and lifestyle details from each participant in a readily retrievable form (Bates et al., 2002) . Archived blood, NAF, and human milk samples from the breast cancer cases and from an appropriately matched group of controls without breast cancer would be removed from storage and analyzed (both for levels of chemicals and biological changes) according to the available methods and prevailing hypotheses of the day. Appropriate statistical methods would then be used to seek associations between levels of environmental chemicals or biological changes and breast cancer risk.
In a typical case-control study, the assessment of the study participants for the health end point of interest would be completed once the associations between exposure and health effect were assessed. However, the incidence of breast cancer is high, and a ''control'' can become a ''case.'' The use of previous controls as cases later in the study is normal epidemiologic procedure under what is known as incidencedensity sampling. There would be two study records for the purpose of analysis F one as a case the other as a control. To exclude the former control would introduce bias (although perhaps not substantially, as the proportion of controls becoming cases would be small). This type of study design is worth pursuing despite the substantial problems that might occur involving adequate and comprehensive follow-up processes, including identification of those who become breast cancer cases during the cohort follow-up period, which can be especially hard in mobile societies.
There are still many unknowns that can affect the usefulness of this type of study, for example whether DNA adducts of interest are stable enough to survive long-term freezing. No such study has yet been published. As NAF and human milk sampling and the availability of sufficiently sensitive chemical analytic methods is relatively recent, it may still be several decades before the results of a study seeking associations between breast cancer and chemical levels could be anticipated, even if such a study is already underway.
Chemical selection
Research using samples of breast tissues and fluids to cast light on the etiology of breast cancer is, for the most part, predicated on one major assumption F that the tissue or fluid samples either contain measurable traces of the environmental and dietary agent(s) responsible for the cancer or they retain biological changes that are biomarkers of such exposure or precursors of carcinogenic effect. This is a major assumption and may not be correct. For example, most agents whose concentrations have been measured in human milk are fat soluble, including PCBs, dioxins, and organochlorine pesticides. Yet key etiologic agents for breast cancer may well be water soluble with low fat solubility. The concentrations of such agents found in human milk will be related to recent exposures, fluctuate markedly over time, and are unlikely to be easily associated with cancer risk. Thus, the continuing focus on lipid-soluble chemicals in human milk such as persistent organochlorine compounds may be analogous to looking for the proverbial lost keys under the lamp-post. Other chemicals have received less attention but may be worth further exploration. For example, occupational studies have shown associations between methylene chloride, carbon tetrachloride, formaldehyde, styrene, benzene, and PAHs and breast cancer (Brody and Rudel, 2003) . Expansion of the chemicals selected is needed, with inclusion of endocrine-active agents and those that bind to DNA.
In addition, potentially fruitful areas of laboratoryoriented research include the development of more sensitive and cheaper analytical methods for analyzing concentrations of environmental chemicals in smaller quantities of human milk and NAF, and cytological methods for examination of changes in the cells found in human milk. As DNA damage and mutations from carcinogens appear to differ from those resulting from endogenous processes, Biggs et al. (1993) propose the use of mutational analysis to identify subgroups of cancer patients with patterns of mutations that differ from background or endogenous patterns. Epidemiological studies could then focus on these subgroups.
In conclusion, serum, human milk, and NAF fluids, and the cells contained therein, hold promise for future biomonitoring research into breast cancer etiology, but this research must be conducted with carefully delineated hypotheses and a scientifically supportable epidemiological approach, with consideration of early life exposures.
